Hanjo Kim
AI Drug Discovery Consultant Zifo
Dr. Hanjo Kim is a drug discovery expert with extensive experience spanning medicinal chemistry, cheminformatics, AI-driven drug discovery, and pharmaceutical informatics. At Zifo, he helps accelerate R&D through digital transformation, data strategy, and advanced informatics solutions. Throughout his career, he has led drug discovery programs across academia, biotech, and pharmaceutical companies, including leadership roles at Standigm, where he advanced AI-enabled approaches to target identification and lead optimization. With expertise in QSAR, molecular modeling, cheminformatics, and medicinal chemistry, Dr. Kim is passionate about integrating computational technologies and scientific knowledge to improve the efficiency and success of drug discovery.
Seminars
- Understanding the value of short-term, smaller impact improvements to accelerate and improve drug discovery with AI, in parallel to long-term, large impact cases
- Exploring case studies of AI applications for validation of data integrity and standardization to improve the reliability and speed of drug discovery
- Looking ahead: Laying out predictions for how AI tools will progress to reshape innovative drug discovery
